# Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation

> **NCT02742805** · PHASE4 · WITHDRAWN · sponsor: **Selina Gierer, D.O.**

## Conditions studied

- Urticaria

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin D (4,000 IU/day)
- **DIETARY_SUPPLEMENT:** Vitamin D (400 IU/day)
- **DRUG:** Omalizumab

## Key facts

- **NCT ID:** NCT02742805
- **Lead sponsor:** Selina Gierer, D.O.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02742805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02742805, "Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02742805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*